Hematology Allogeneic Stem Cell Transplantation: Expert Review and Commentary Dr. Mattias Stelljes, Dr. Thomas J. Nevill & Dr. Victor Lewis Conditioning for Allogeneic Hematopoietic Stem Cell: Strategies Compared Download 2 PowerPoint slides
Hematology Waldenström Macroglobulinemia: Expert Interview Dr. Laurie H Sehn — Length: 06:19 A Canadian Perspective on the Role of BTK Inhibitors in the Treatment of WM Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Carolyn Owen — Length: 05:00 ALPINE Trial Demonstrates Superior Response of Second-Generation BTK Inhibitor in CLL/SLL Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana ALPINE Head-to-head Trial, Second-generation BTK Inhibitor Shown to be More Effective and Safer in CLL Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Dennis Kim — Length: 05:18 STAMP Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana Novel Small Molecule Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Laurie H. Sehn — Length: 05:00 New Data Shifts Risk-benefit of BTK Inhibitors in CLL/SLL Watch Presentation
oncology European Society of Medical Oncology (ESMO) 2022: Expert Interview Dr. Karen Gelmon — Length: 05:26 Reviewing Overall Survival from Large Multicenter Trials: CDK4/6 Inhibitors for Advanced Breast Cancer Watch Presentation
oncology European Society of Medical Oncology (ESMO) Congress 2022 September 9-13, 2022 — Paris, France Gaining Further Perspective into Treatment of Advanced Breast Cancer with CDK4/6 Inhibitors Download 4 PowerPoint slides
oncology Biliary Tract Cancer: Expert Interview Dr. Vincent Tam — Length: 04:33 Clinical Impact of Immunotherapy for Advanced Biliary Tract Cancer Watch Presentation
oncology Biliary Tract Cancer: Expert Review and Commentary from Published Literature Dr. Vincent Tam A Promise for Change in First-line Standard of Care for Biliary Tract Cancer Download 4 PowerPoint slides
Hematology 2022 European Hematology Association (EHA) Congress Dr. Carolyn Owen — Length: 05:14 Long-term ASPEN Data: Demonstrated Efficacy and Tolerability in Patients with Waldenström Macroglobulinemia Watch Presentation